Anya Biopharm (ROCO:7776) Net Margin %: 34.73% (As of Dec. 2025)


ROCO:7776 Anya Biopharm Inc ROCO:7776
12 GF Score
Price NT$31.80
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm Net Margin %?

Anya Biopharm ROCO:7776 12 Net Margin % is 34.73% as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 941 Biotechnology companies, Anya Biopharm ranks worse than 68.44% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Anya Biopharm's Net Income for the six months ended in Dec. 2025 was NT$4.28 Mil. Anya Biopharm's Revenue for the six months ended in Dec. 2025 was NT$12.33 Mil. Therefore, Anya Biopharm's net margin for the quarter that ended in Dec. 2025 was 34.73%.

The historical rank and industry rank for Anya Biopharm's Net Margin % or its related term are showing as below:

ROCO:7776' s Net Margin % Range Over the Past 10 Years
Min: -1675.92   Med: -802.15   Max: -171.14
Current: -393.47

ROCO:7776's Net Margin % is ranked worse than
68.44% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:7776: -393.47

Anya Biopharm  (ROCO:7776) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Anya Biopharm Net Margin % Related Terms

Anya Biopharm Net Margin % Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm Net Margin % Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Margin %
-1,675.92 -1,210.82 -171.14 -393.47

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial -1,493.64 -4,296.14 -32.95 -1,734.51 34.73

ROCO:7776 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Anya Biopharm's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anya Biopharm Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anya Biopharm's Net Margin % distribution charts can be found below:

* The bar in red indicates where Anya Biopharm's Net Margin % falls into.


ROCO:7776
12GF Score
Anya Biopharm Inc ROCO:7776
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Anya Biopharm's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-64.022/16.271
=-393.47 %

Anya Biopharm's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=4.283/12.333
=34.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 34.73% mean?
Anya Biopharm (ROCO:7776) has a Net Margin % of 34.73% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Anya Biopharm and its competitors. According to the industry distribution chart, Anya Biopharm ranks #644 out of 941 companies in the Biotechnology industry, placing it in the top 68.4%.
Is Anya Biopharm's Net Margin % too high?
Anya Biopharm's current Net Margin % is 34.73%. Based on the distribution chart, Anya Biopharm ranks #644 out of 941 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Anya Biopharm has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anya Biopharm ranks #644 out of 941 companies for Net Margin %. This places Anya Biopharm in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current Net Margin % is 34.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current Net Margin % of 34.73%. The current Net Margin % is 34.73%. Anya Biopharm's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current Net Margin % is 34.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
12GF Score

Get the complete analysis for ROCO:7776

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.80
Price